Dyadic International, Inc. Reports First Quarter 2013 Financial Results
5/16/2013 6:46:49 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
JUPITER, Fla., May 15, 2013 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company, today announced financial results for the quarter ended March 31, 2013.
Dyadic's President and Chief Executive Officer, Mark Emalfarb, stated, "The highlights of Dyadic's first quarter are continuing momentum in our industrial enzyme business and commercialization of our C1 enzyme expression platform.
Help employers find you! Check out all the jobs and post your resume.